Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men



Status:Archived
Conditions:Obesity Weight Loss, Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:July 2010

Use our guide to learn which trials are right for you!

An Open-label Dose Finding Study Followed by a Parallel Group, Randomized, Double-blind Study to Evaluate the Safety, Tolerability and Pharmacodynamics of 12 Week BGS649 Treatment in Obese, Hypogonadotropic Hypogonadal Men


This study is designed as a 2-part study, with Part 1 being open-label to best determine the
appropriate dose levels to use in Part 2, which has a randomized, double-blind, placebo
controlled design. The study aims to assess the safety and tolerability of BGS649, and
determine whether or not BGS649 is able to normalize testosterone levels and improve
insulin sensitivity in obese, hypogonadotropic hypogonadal (OHH) men



We found this trial at
4
sites
6719 Alvarado Road
San Diego, California 92120
619-287-6000
?
mi
from
San Diego, CA
Click here to add this to my saved trials
?
mi
from
Mirmar, FL
Click here to add this to my saved trials
?
mi
from
Tuscon, AZ
Click here to add this to my saved trials
West Valley, Utah 84120
?
mi
from
West Valley, UT
Click here to add this to my saved trials